Dr Matthias Schwenkglenks

Main Interest

Dr Schwenkglenks’ main research interests include:

  • Biostatistics (including advanced multivariate regression modelling and multilevel modelling)
  • Observational study and clinical trial design
  • Epidemiology
  • Health services research
  • Health economics and health economic evaluation (including decision-analytic modelling)

 

Current Position

Matthias Schwenkglenks is Head of Research at the Institute of Pharmaceutical Medicine (ECPM) at the University of Basel, Switzerland. He also leads the Division of Medical Economics at the Institute of Social and Preventive Medicine of the University of Zurich, Switzerland.    

 

Education

Dr Schwenkglenks started his career in the medical field at the University Hospital in Tübingen, Germany, where he qualified as an intensive care nurse. During this time he also obtained a Master of Arts in sociology and political sciences.  

 

Whilst holding a position of research fellow in the Division of Medical Economics, University Hospital of Zürich, he gained a Master of Public Health as part of a postgraduate program at the Universities of Basel, Bern and Zürich, Switzerland.  

 

Before taking up his current position at the University of Basel, he headed the Medical Economics division in the Hirslanden Holding Group of Private Clinics in Zürich, Switzerland.

 

In 2006, he obtained a PhD in Epidemiology (thesis title: Multilevel modelling in the analysis of observational datasets in the health care setting) from the University of Basel, Switzerland. He received the Venia legendi in "Health Economics and Public Health" from the University of Zurich in 2009. 

 

Other Activities

Dr Matthias Schwenkglenks is a reviewer for peer-reviewed journals including Health Affairs, Value in Health, Medical Decision Making, The American Journal of Managed Care, Cardiovascular Drugs and Therapy and the European Journal of Cardiovascular Prevention and Rehabilitation.  

Last update: 2011-08-10

The content of this website is intended for healthcare professionals.
All content is approved by the INC-EU study group members.

The INC-EU and this website are supported by an educational grant from

Amgen (Europe) GmbH.